Patents
Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
02/2004
02/24/2004US6696403 Composition and method for bleaching a substrate
02/24/2004US6696301 Method for determination of 5-hydroxycreatinine
02/24/2004CA2279186C Sulfonyl urea derivatives and their use in the control of interleukin-1 activity
02/19/2004WO2004014973A2 Biodegradable polymer
02/19/2004WO2004014871A1 Vanilloid receptor ligands and their use in treatments
02/19/2004WO2004014847A1 Mcp-1 receptor antagonists and method of use thereof
02/19/2004WO2004014844A2 Aryl and heteroaryl compounds and methods to modulate coagulation
02/19/2004WO2004014825A1 Cannabinoid receptor ligands
02/19/2004WO2004014550A2 Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their production and use in catalytic reactions
02/19/2004WO2002091989A3 Antiviral therapies using polyamine or polyamine analog-amino acid conjugates
02/19/2004WO2002080869A3 Novel dyeing composition for dyeing keratinous fibres comprising a particular dicationic monoazo dye
02/19/2004US20040034231 Amidinophenyl-4-aminoacetic acid derivative is useful for treating diseases such as thrombosis, apoplexy, cardiac infarction, inflammation and arteriosclerosis, which are associated with coagulation factors xa, IXa and thrombin
02/19/2004US20040034103 Cdc25 photophatase inhibitors
02/19/2004US20040034089 Such as (1-((2,3-dihydro-2-(4-propyl-1H-imidazol-2-yl)-1H-indol-1 -yl)carbonyl)propyl)-carbamate; for inactivation of cholecystokinins
02/19/2004US20040034079 Imidazole alkaloids from lepidium meyenii and methods of usage
02/19/2004US20040033995 Nitrogen compounds, stereoisomers and/or racemic mixtures used as enzyme inhibitors for prophylaxis of inflammatory diseases
02/19/2004US20040033935 Novel imidazole derivatives, production method thereof and use thereof
02/19/2004US20040033892 Ion liquids derived from lewis acid based on titanium, niobium, tantalum, tin or antimony, and uses thereof
02/19/2004DE19934231B4 Verfahren zur Herstellung von 1-substituierten 5-Hydroxy-imidazolin-2,4-dionen und 1-substituierten 5-Alkoxy-imidazolin-2,4-dionen A process for preparing 1-substituted 5-hydroxy-imidazoline-2,4-diones and 1-substituted 5-alkoxy-imidazoline-2,4-diones
02/19/2004CA2495067A1 Mcp-1 receptor antagonists and method of use thereof
02/19/2004CA2494827A1 Cannabinoid receptor ligands
02/19/2004CA2493008A1 Aryl and heteroaryl compounds and methods to modulate coagulation
02/18/2004EP1389460A1 Cxcr4-antagonistic drugs comprising nitrogen-containing compound
02/18/2004EP1389107A1 Bisarylimidazolyl fatty acid amide hydrolase inhibitors
02/18/2004EP1286953B1 (p-amino-hydroxyphenyl)-acrylamide derivatives and dyes containing said compounds
02/18/2004EP1178958B1 N-cyanomethyl amides as protease inhibitors
02/18/2004EP1169301B1 A topical antiandrogen for hair loss and other hyperandrogenic conditions
02/18/2004EP1076663B1 Functionalized alkyl and alkenyl side chain derivatives of glycinamides as farnesyl transferase inhibitors
02/18/2004CN1476424A 萘衍生物 Naphthalene Derivatives
02/18/2004CN1475484A Preparation methoh of tinidazole
02/18/2004CN1475483A Single imidazole/multiamine acylamide kind compound and its synthesis method and use
02/18/2004CN1138760C Preparation and use of ortho-sulfonamido bicyclic heteroaryl hydroxamic acids as matrix metalloproteinase and TACE inhibitors
02/18/2004CN1138546C Certain 1,4,5-tri-substituted imidazole compounds useful as cytokine
02/18/2004CN1138472C Dipeptide apoptosis inhibitors and use thereof
02/17/2004US6693200 2-(substituted-phenyl)amino-imidazoline derivatives
02/17/2004US6693199 Deprotecting carbamate group and amidating in presence of such as hydroxybenzotriazole hydrate promoter
02/17/2004US6693123 (4-(3-pyridylaminomethylene)-2-phenylbenzoyl)-n -methylmethionine, methyl ester for example; restenosis, hyperplasia
02/17/2004US6693113 As immunomodulators and for inducing cytokine biosynthesis in animals, for therapy of viral infections
02/12/2004WO2004013629A2 Screening for agents suitable for treatment of leukocyte associated inflammatory diseases
02/12/2004WO2004013282A2 Bis (amino acid) molecular scaffolds
02/12/2004WO2004013234A2 Metal complexes as light-absorbing compounds in the information layer of optical data carriers
02/12/2004WO2004013112A1 Pesticidal fluoroalkene derivatives
02/12/2004WO2004013108A1 Method and compounds for promoting healing and reducing inflammation
02/12/2004WO2004012659A2 Nitrosated proton pump inhibitors, compositions and methods of use
02/12/2004WO2004012648A2 Substituted diaryl heterocycles, method for the production and use thereof as medicaments
02/12/2004WO2003097582A3 Synthesis of benzonitriles and benzimidates
02/12/2004WO2003049702A3 Vanilloid receptor ligands and their use in treatments
02/12/2004WO2002100344A3 Amino acid conjugates providing for sustained systemic concentrations of gaba analogues
02/12/2004WO2002058698A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators
02/12/2004US20040030132 Anticancer agents; arterosclerosis; bone disorders; antiarthritic agents; vision defects
02/12/2004US20040030123 Method for producing molecular compound
02/12/2004US20040030085 Using isocyanate dimers, trimer for polyurethanes
02/12/2004US20040029943 Antiallergens; antiinflammatory agents; hypotensive agents; central nervous system disorders
02/12/2004US20040029935 Heterocyclic aromatic compounds useful as growth hormone secretagogues
02/12/2004US20040029862 Alzheimer's disease
02/12/2004US20040029814 Cathepins inhibitor; antiinflammatory agents; antiarthritic agents
02/12/2004US20040029746 Wear resistance, oil additive
02/12/2004US20040029745 Wear resistance; oil additive
02/12/2004US20040029742 Bicyclic thioureas as additives for lubricating oils
02/12/2004US20040029720 Supported group 8-10 transition metal olefin polymerization catalysts
02/12/2004US20040026666 Imidazolium salts and their use of these ionic liquids as a solvent
02/12/2004DE10233817A1 Substituierte Diarylheterocyclen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted Diarylheterocyclen, processes for their preparation and their use as medicaments
02/12/2004CA2494408A1 Method and compounds for promoting healing and reducing inflammation
02/12/2004CA2493618A1 Nitrosated proton pump inhibitors, compositions and methods of use
02/11/2004EP1387837A1 Novel azole or triazole derivatives, method for preparing same and use thereof as antifungal medicines
02/11/2004EP1007503B1 New chemical compound suitable for use as an explosive, intermediate and method for preparing the compound
02/11/2004EP0797567B1 Novel amino acid derivatives with improved multi-drug resistance activity
02/11/2004CN1474819A Novel imidazole derivatives, production method thereof and use thereof
02/11/2004CN1474813A Substituted 2-phenylaminomidazoline phenyl ketone derivatives as IP antagonists
02/11/2004CN1474803A Novel amide derivatives and medicinal use thereof
02/11/2004CN1474689A CDC25 phosphatase inhibitors
02/11/2004CN1473817A Process for preparing 1-chloroformyl-3-mesyl imidazolidylone
02/10/2004US6689928 Prepared in situ from a nickel, palladium or platiinum compound and a nitrogen-containing ligand; oligomerizing olefin monomers
02/10/2004US6689886 Treatment of inflammation and other immune disorders
02/10/2004CA2291975C Quaternary ammonium compounds
02/05/2004WO2004011446A1 Indane, dihydrobenzofuran, and tetrahydronaphthalene carboxylic acid derivatives and their use as antidiabetics
02/05/2004WO2004011438A1 Diaryl-substituted cyclic urea derivatives having an mch-modulatory effect
02/05/2004WO2004011437A1 Novel imidazole alcohol compound, process for producing the same, and surface-treating agent comprising the same
02/05/2004WO2004011423A2 Structural carotenoid analogs for the inhibition and amelioration of disease
02/05/2004WO2004011402A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof
02/05/2004WO2004010950A2 Aryl substituted hydantoin compounds and their use as sodium channel blockers
02/05/2004WO2004010949A2 Compounds active in spinigosine 1-phosphate signaling
02/05/2004WO2003075857A3 Amino-methyl substituted tetracycline compounds
02/05/2004WO2003074475A3 Substituted aryl ketones
02/05/2004WO2002048973A3 A remote control account authorization system
02/05/2004US20040024224 Synthesis of 2-alkyl amino acids
02/05/2004US20040024223 From a clathrate compound comprising 1,5-bis-(3',5-dinitro-1',2',4'-triazolo)-2,4-dinitrazapentane; for use in gun/rocket propellants and explosives
02/05/2004US20040024208 Cyclic protein tyrosine kinase inhibitors
02/05/2004US20040024205 Monomethylation of nitrogeneous heterocycles
02/05/2004US20040024067 Deacetylase inhibitors
02/05/2004US20040024039 Having a steroid C17,20-lyase inhibitory activity; useful as prophylactic or therapeutic agent for prostate and breast cancers
02/05/2004US20040024038 GABA enhancers in the treatment of diseases relating to reduced neurosteroid activity
02/05/2004US20040024014 Such as 2-(nitrooxy)ethyl-2-(((3-methyl-4-(2,2,2-trifluoro-ethoxy)-2 -pyridyl)methyl)sulfinyl)benzimidazolecarboxylate; kits; for treating gastrointestinal disorders/ulcers
02/05/2004US20040023999 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
02/05/2004US20040023986 Treating epilepsy, neuropathic pain, and tissue damage form ischemic events; antihypoxic agents
02/05/2004US20040023950 N-heterocyclic derivatives as NOS inhibitors
02/05/2004US20040023932 Imidazonaphthyridine and tetrahydroimidazonaphthyridine compounds induce the biosynthesis of cytokines such as interferon and tumor necrosis factor. The compounds exhibit antiviral and antitumor properties. Methods of preparing the
02/05/2004US20040023929 Small molecules for inhibition of function and drug delivery to leukocytes
02/05/2004US20040023806 Agrochemicals in agriculture for controlling acarids and insects and for preventing the infestation of crop plants by phytopathogenic fungi.
02/05/2004US20040023290 Novel therapeutic agents that modulate enzymatic processes